Nanobody, also known as single domain antibody or VHH, is camelid-generated heavy-chain-only antibody; this small size antigen-binding molecule demonstrates a number of distinct properties and has broad prospects in antibody drug and diagnosis. When compared with traditional monoclonal antibody, nanobody show superior advantages in construction of multi-specific antibody, tissue penetration, hard-to-target epitopes, cost-effective-manufacturing in different host species. iCareAB offer one-stop customized and flexible nanobody development services to worldwide clients. Our proprietary display platforms, highly experienced scientist, self-owned animal research farm, and well-equipped laboratories make us an excellent choice for your nanobody projects. Worldwide customers interested in nanobody technology are welcomed to contact us.
Highly diversified phage libraries (Up to 10^11)
Extensively validated bio-panning strategies, especially cell-based panning for multi-spanning membrane proteins
Fast turnaround time
Guaranteed delivery of candidate binders
Proprietary yeast display platform
Highly diversified yeast library (Up to 10^9)
Powerful tool in functional nanobody screening
Guaranteed delivery of candidate binders
Very fast turnaround time
Straight-forward from cell to candidates sequences
Void tedious construction of display libraries
NGS-facilitated deep-mining methods
Very fast turnaround time
